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Long-Term Outcomes after Robotic-Assisted 
Ivor-Lewis Esophagectomy
Ali Ghandour, Pridvi Kandagatla, Ali Amro, Andrew Popoff, Zane Hammoud
Department of Surgery and Division of Thoracic Surgery, Henry Ford Health 
System/Wayne State University, Detroit, MI
Introduction/Purpose
 Esophageal cancer is the 6th leading cause of cancer-related deaths 
worldwide1
 Surgery remains the mainstay for treatment- Ivor-Lewis esophagectomy being 
the most common
 Robotic assistance (RAIL) affords better visualization and degrees of freedom
 Elucidate the long term outcomes of robotic assisted Ivor-Lewis 
esophagectomy
Methods
 We  performed a retrospective 
review of 112 consecutive 
patients undergoing RAIL 
surgery at our institution.
Table 1. Patient Demographics
Patient Characteristic Number of Patients %
Age (Mean [SD]) 63.1 [9.41]
Male 90 80.4
BMI (Mean [SD]) 27.13 [5.70]
Neoadjuvant Therapy 82 73.2
Smoking History 87 77.7
Pre-operative Albumin (Mean [SD]) 3.66 [0.49]
Hypertension 62 55.4
Coronary Artery Disease 18 16.1
Diabetes 33 29.5
Gastroesophageal Reflux Disease 58 51.8
COPD 19 17
Pre-operative J Feeding Tube 15 13.4
Pre-operative G Feeding Tube 3 2.7
Pre-operative Dysphagia 86 76.8
Methods – Surgical Technique
 Laparoscopic gastric mobilization and creation of the gastric conduit
 Robotic transthoracic esophagectomy and anastomosis above the level of the 
azygous vein utilizing a linear stapler for the posterior wall and manual suture 
for the front wall.
Results
Table 2. Tumor Type
Histologic Type Number of Patients %
Adenocarcinoma 98 87.5
Squamous Cell Carcinoma 3 2.68
High Grade Dysplasia 2 1.79
Other 9 8.04
Table 4. Postoperative Complications
Postoperative Complication
Number of 
Patients %
Arrhythmia 30 26.8
Anastomotic Leak 9 8.0
Stricture Requiring Dilation 18 16.1
Myocardial Infarction 0 0.0
Pneumonia 12 10.7
Vent Dependent Respiratory 
Failure 10 8.9
Reintubation 15 13.4
Acute Renal Failure 5 4.5
Surgical Site Infection 4 3.6
Pleural Effusion 15 13.4
Chylothorax 2 1.8
Deep Vein Thrombosis 2 1.8
Stroke 0 0.0
Delayed Gastric Emptying – 6 
Months* 16 18.4
Delayed Gastric Emptying – 12 
Months* 3 4.2
30-day Mortality 1 0.9
Results
Discussion
 Robotic surgery did not compromise surgical margin 
 16% of our patients developed a stricture requiring at least one dilation, this 
is lower than the 23-42% of stricture rates reported in literature after an open 
esophagectomy2,3
 30 day mortality rate of 0.9%
 Overall survival and disease free survival results are comparable to 
thoracoscopic minimally invasive esophagectomy data4
 Limitations
Conclusion
 Demonstrate the feasibility and safety of a RAIL esophagectomy
 Outcomes are similar to other non-robotic esophagectomies
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